Atnaa

   
Google
 
Web NewDrugInformation.com

Atnaa


Drug - Atnaa
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INTRAMUSCULAR
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Atropine; Pralidoxime Chloride
Multiple ingredients are in alphabetical order.

Strength - 2.1MG/0.7ML,N/A;N/A,600MG/2ML
The potency of the active ingredient(s), Atropine; Pralidoxime Chloride. May repeat for multiple part products.

Applicant - US ARMY
The firm name holding legal responsibility for Atnaa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021175
The FDA assigned number to Atnaa. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Atnaa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 17, 2002
The date Atnaa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Atnaa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Atnaa is in. Format is RX, OTC, DISCN.

Applicant Full Name - Us Army Medical Research Materiel Command
The full name of the firm holding legal responsibility for the new application of Atnaa.

Atnaa